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addittion, we examined the same above-mentioned parameters to find for the
predictors for late recurrence using uni/multivariate analyses.
Results: S group consisted of 31 patients (35.2%). The incidence of late recur-
rence was higher in F group than in S group (36.8% vs 16.1% p=0.042), while
there were no significant differences in clinical characteristics between the two
groups. In F group, univariate analysis demonstrated left ventricular end-diastolic
diameter (LVDd) (>47mm) which showed good accuracy by receiver operating
characteristics (AUC-ROC: 0.649), sinus conversion by primary IDC and relapse
of AF/AT during procedure were correlated with late recurrence. Multivariate anal-
ysis using these parameters revealed that LVDd (>47mm) and relapse of AF/AT
during procedure were independently correlated with late recurrence in F group
(Table 1).
Table 1
Univariate analysis Multivariate analysis
OR 95% CI P value OR 95% CI P value
LVDd (>47mm) 3.40 1.02–13.6 0.047 1.94 1.18–24.4 0.028
LAD (>45mm) 3.31 0.90–12.2 0.073 3.64 0.87–19.1 0.079
Sinus conversion by primary IDC 4.40 1.02–23.1 0.047 1.76 0.32–11.2 0.519
Relapse of AF/AT during procedure 8.40 2.33–40.6 <0.001 9.44 2.14–55.6 0.002
Conclusion: Poor response of IDC just before PVI in PerAF patients was re-
lated with late recurrence. In the poor response of IDC group, LVDd and relapse
of AF/AT during procedure were independent factors associated with late recur-
rence.
P4829
Atrial fibrillation ablation: the added value of adenosine test in
confirming pulmonary vein isolation
A. Nunes-Ferreira, J.R. Agostinho, N. Cortez-Dias, G. Lima Da Silva,
A.R. Francisco, T. Guimaraes, I. Santos Goncalves, I. Aguiar-Ricardo,
J. Rigueira, A. Bernardes, L. Carpinteiro, F.J. Pinto, J. De Sousa. Cardiology
Dept., Santa Maria Hospital, CHLN, CCUL, Lisbon University, Lisbon, Portugal
Introduction: Adenosine test has been increasingly used to confirm pulmonary
vein isolation (PVI) in patients undergoing ablation of atrial fibrillation (AF). How-
ever, its impact on the success of ablation remains unknown.
Purposes: To evaluate the results of the adenosine triphosphate (ATP) test in
patients undergoing PVI and assess the success of ablation related to the use of
this test (adenosine-guided PVI versus conventional PVI).
Methods: Single-center prospective study of consecutive patients undergoing
first AF ablation procedure, started at January 2013. After ablation, the persis-
tence of PVI was tested with adenosine triphosphate administration (15–30mg by
intravenous route). When adenosine triphosphate-induced pulmonary vein con-
duction (termed as reconduction) was observed, additional energy applications
of radiofrequency were applied to obtain persistent isolation on retesting. Cardiac
event recorder was performed at 7 days, 3, 6 and 12 months after ablation and
annually from the 2nd year.
The adenosine triphosphate-induced reconduction rate was evaluated depending
on the pulmonary vein involved. The impact of adenosine test implementation
in the success of the ablation at 365 days (recurrence of AF or supraventricular
tachycardia) was determined by analysis of overall survival using Kaplan-Meier
method.
Results: Adenosine test was performed on 151 patients, with reconduction de-
tected on at least one of the pulmonary veins in 11 patients (33.8%) and in 17.6%
of the 641 pulmonary veins evaluated, with no statistically significant difference
between the different veins. The overall success rate of AF ablation at 365 days
was 72% and did not differ significantly between adenosine-guided PVI versus
conventional PVI (74.3% versus 70.8%, P = NS), although the duration of follow-
up had been shorter in the first group (median of 13.0 vs. 38.3 months; p<0.001).
Conclusion: The adenosine-induced reconduction occurs in about one third of
the patients. However, the additional adenosine-guided energy applications do
not seem to increase the overall success of ablation. We found no significant
reduction in the 1 year incidence of recurrent atrial tachyarrhythmias by ATP-
guided PVI compared with conventional PVI.
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Background: Radiofrequency ablation (RFA) is a well-established treatment op-
tion for symptomatic patients with atrial fibrillation (AF). However, the success
rate of a single procedure is low. Identifying patients in whom sinus rhythm main-
tenance cannot be achieved after RFA is a critical issue.
Purpose: We aimed to evaluate the association between the pre-ablation plasma
concentration of the mid-regional fragment of the N-terminal of pro-atrial natri-
uretic peptide (MR-proANP), the left atrial ejection fraction (LA EF) and the risk
of recurrence of AF after a single RFA procedure.
Methods: We studied 187 patients undergoing RFA of AF between January 2012
and April 2014 and followed them up for 12 months. The levels of MR-proANP
and left atrial ejection fraction (LA EF) were accessed before RFA. Episodes of
AF lasting more than 30 seconds during the follow up period were classified as
clinical recurrences, in accordance with the 2012 consensus statement from the
Heart Rhythm Society and others. A logistic regression analysis was performed
to check the association between MR-proANP, LA EF and the risk for recurrence
of AF after a single RFA procedure. This analysis was adjusted for various covari-
ates such as age, gender, body mass index and type of AF.
Results: In total 119 (63.6%) patients had a recurrence of AF during a mean
follow-up period of 402±73 days. An increased concentration of MR-proANP be-
fore RFA was associated with an increased risk of recurrence (fourth quartile vs.
first quartile: 78% vs 56.3%, respectively; hazard ratio [HR], 2.8 [95% confidence
interval {CI}, 1.14–6.9]; P=0.025). Additionally, low LA EF was associated with
an increased risk of recurrence (fourth quartile vs. first quartile: 48.8% vs 69,7%,
respectively; HR, 2.41 [95% CI, 1.006 -5.786]; P=0.045).
Predictors of recurrence after RFA of AF
Conclusions: Among patients who undergo RFA of AF, elevated concentrations
of MR-proANP and low LA EF were associated with increased risk of recurrence
of AF after a single RFA procedure. These findings are consistent with the hypoth-
esis that patients with better mechanical and neurohormonal LA function have a
better outcome after a single RFA procedure.
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Objective: To assess the incidence and predictors of heart rhythm and conduc-
tion disturbances in postinfarct patients with and without obstructive sleep apnea
(OSA).
Methods: This is an open, cohort, prospective study. Out of 193 screened pa-
tients, we selected 176 postinfarct individuals (more than 1 month) without severe
concomitant diseases: 75 patients without sleep-disordered breathing (non-SDB
group), and 101patients with OSA (OSA group). At baseline, all patients under-
went examination, including ECG, Holter ECG monitoring, and sleep study. Dur-
ing follow-up (on 1,2,3 and 4th years; phone calls once per 6 months), information
about new events, changes in therapy and life style was collected, diagnostic pro-
cedures were performed. As the endpoints, we registered significant heart rhythm
and conduction disorders as following: atrial fibrillation (AF), ventricular tachy-
cardia, atrioventricular block (AV) 2–3 degree, sinoatrial block, significant sinus
pauses (>2000 ms), and the required pacemaker implantation.
Results: The median follow-up was 48 (24.5–52) months. The frequency of heart
rhythm disorders was higher in OSA patients (24 cases, χ2 = 8.5; P=0.017) com-
pared to the non-SDB patients (three cases; OR: 2. 92, 95% CI: 1.16–13.19). AF
was registered in 17 patients (n=13in OSA group; P=0.05). Heart conduction dis-
turbance developed in 13 patients, without an association with the rate of coronary
artery disease onset. Regression analysis showed that only hypertension dura-
tion was an independent predictor of AF (OR: 1.10, 95% CI: 1.02–1.15; P=0.005).
In case of heart conduction disturbances, apnea duration was the strongest pre-
dictor (P=0.005).
Conclusions: Patients in posrinfarct period with OSA demonstrate 4-fold higher
incidence of heart rhythm and conduction disturbances than subjects without
SDB. Hypertension duration is an independent predictor for AF development,
while sleep apnea/hypopnea duration is the main factor for heart conduction dis-
orders onset in patients with OSA, postinfarct.
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